Increased glycemic variability associated with a poor 30-day functional outcome in acute intracerebral hemorrhage

Restricted access

The authors analyzed the association between the standard deviation or the coefficient of variation in the glucose value, strong independent indexes for determining glycemic variability, and the prognosis of intracerebral hemorrhage. They found that glycemic variability may be associated with a poor outcome in intracerebral hemorrhage.

ABBREVIATIONS AUC = area under the receiver operating characteristic curve; CV = coefficient of variation; DBP = diastolic blood pressure; DM = diabetes mellitus; FBG = fasting blood glucose; GCS = Glasgow Coma Scale; GluCV = coefficient of variation of glucose; GluSD = standard deviation of glucose; GV = glycemic variability; HbAlc = glycosylated hemoglobin; HDL-C = high-density lipoprotein cholesterol; ICH = intracerebral hemorrhage; IVH = intraventricular hematoma; LDL-C = low-density lipoprotein cholesterol; MI = myocardial infarction; mRS = modified Rankin Scale; NG = normal glucose; SBP = systolic blood pressure; SD = standard deviation; SHG = stress hyperglycemia; TC = total cholesterol; TG = triglyceride; WBC = white blood cell.

Article Information

Correspondence Qing-Ying Zhang, Department of Preventive Medicine, Shantou University Medical College, 22 Xinling Rd., Shantou, Guangdong 515041, China. email: qyzhang@stu.edu.cn.

INCLUDE WHEN CITING Published online November 3, 2017; DOI: 10.3171/2017.4.JNS162238.

Disclosures The authors report no conflict of interest concerning the materials and methods used in this study or the finding specified in this paper.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Dynamic changes in 7-day FBG level in 3 glucose groups of hospitalized patients with ICH. Figure is available in color online only.

  • View in gallery

    Poor prognosis and mortality rate at 30 days in 3 glucose groups of hospitalized ICH patients.

  • View in gallery

    Receiver operating characteristic curves for the original, GluSD (SD), and GluCV (CV) models for predicting 30-day poor outcome in ICH. Figure is available in color online only.

References

1

American Diabetes Association: (2) Classification and diagnosis of diabetes. Diabetes Care 38 (Suppl):S8S162015

2

Appelboom GPiazza MAHwang BYCarpenter ABruce SSMayer S: Severity of intraventricular extension correlates with level of admission glucose after intracerebral hemorrhage. Stroke 42:188318882011

3

Béjot YAboa-Eboulé CHervieu MJacquin AOsseby GVRouaud O: The deleterious effect of admission hyperglycemia on survival and functional outcome in patients with intracerebral hemorrhage. Stroke 43:2432452012

4

Bloch RF: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:14481988

5

Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:161516252005

6

Clement SBraithwaite SSMagee MFAhmann ASmith EPSchafer RG: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27:5535912004 (Erratum in Diabetes Care 27:856 2004)

7

Dungan KMBinkley PNagaraja HNSchuster DOsei K: The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes Metab Res Rev 27:85932011

8

Dungan KMBraithwaite SSPreiser JC: Stress hyperglycaemia. Lancet 373:179818072009

9

Egi MBellomo RStachowski EFrench CJHart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:2442522006

10

Esposito KNappo FMarfella RGiugliano GGiugliano FCiotola M: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:206720722002

11

Feigin VLForouzanfar MHKrishnamurthi RMensah GAConnor MBennett DA: Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383:2452542014

12

Fogelholm RMurros KRissanen AAvikainen S: Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry 76:3493532005

13

Freire AXBridges LUmpierrez GEKuhl DKitabchi AE: Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 128:310931162005

14

Godoy DAPiñero GRSvampa SPapa FDi Napoli M: Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care 9:2172292008

15

Han JLee HKCho TGMoon JGKim CH: Management and outcome of spontaneous cerebellar hemorrhage. J Cerebrovasc Endovasc Neurosurg 17:1851932015

16

Hanley JAMcNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29361982

17

Hemphill JC IIIGreenberg SMAnderson CSBecker KBendok BRCushman M: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46:203220602015

18

Kothari RUBrott TBroderick JPBarsan WGSauerbeck LRZuccarello M: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:130413051996

19

Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36:300830132008

20

Lovelock CEMolyneux AJRothwell PM: Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 6:4874932007

21

Martin WGGalligan JSimpson S JrGreenaway TBurgess J: Admission blood glucose predicts mortality and length of stay in patients admitted through the emergency department. Intern Med J 45:9169242015

22

Mendez CEMok KTAta ATanenberg RJCalles-Escandon JUmpierrez GE: Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care 36:409140972013

23

Meretoja AStrbian DPutaala JCurtze SHaapaniemi EMustanoja S: SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 43:259225972012

24

Monnier LColette COwens DR: Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2:109411002008

25

Monnier LMas EGinet CMichel FVillon LCristol JP: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:168116872006

26

Palm FHenschke NWolf JZimmer KSafer ASchröder RJ: Intracerebral haemorrhage in a population-based stroke registry (LuSSt): incidence, aetiology, functional outcome and mortality. J Neurol 260:254125502013

27

Piironen KPutaala JRosso CSamson Y: Glucose and acute stroke: evidence for an interlude. Stroke 43:8989022012

28

Rodbard D: Characterizing accuracy and precision of glucose sensors and meters. J Diabetes Sci Technol 8:9809852014

29

Rodbard D: New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 11:5515652009

30

Sacco RLKasner SEBroderick JPCaplan LRConnors JJCulebras A: An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:206420892013

31

Siegelaar SEHolleman FHoekstra JBDeVries JH: Glucose variability; does it matter? Endocr Rev 31:1711822010

32

Stead LGJain ABellolio MFOdufuye AGilmore RMRabinstein A: Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage. Neurocrit Care 13:67742010

33

Tapia-Pérez JHGehring SZilke RSchneider T: Effect of increased glucose levels on short-term outcome in hypertensive spontaneous intracerebral hemorrhage. Clin Neurol Neurosurg 118:37432014

34

Teasdale GJennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81841974

35

Tetri SJuvela SSaloheimo PPyhtinen JHillbom M: Hypertension and diabetes as predictors of early death after spontaneous intracerebral hemorrhage. J Neurosurg 110:4114172009

36

Wang J: Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 92:4634772010

37

Wexler DJNathan DMGrant RWRegan SVan Leuvan ALCagliero E: Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. J Clin Endocrinol Metab 93:423842442008

38

Whitworth JA: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:198319922003

39

Wilson JTHareendran AGrant MBaird TSchulz UGMuir KW: Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke 33:224322462002

40

Yang GWang YZeng YGao GFLiang XZhou M: Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 381:198720152013

41

Zhou YWang YWang JAnne Stetler RYang QW: Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 115:25442014

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 225 225 45
Full Text Views 535 535 49
PDF Downloads 402 402 20
EPUB Downloads 0 0 0

PubMed

Google Scholar